Avid Bioservices Inc (CDMO)

[entdoc]

veets, read my lips: IO is a farce for large solid tumors. IO is the early game, not the end-game. BP is going to school on the money of every one of us investors and patients. Hopefully the spin-offs will be worth the price tag. Treatment for terminal large solid tumors is definitely not worth the cost. It is still surgery, irradiation, or chemo. I can even go along with IO for helping survival stats for surgery and irradiation. Trying to use an immunomodulator/immunostimulator when poisoning the immune system with chemotherapy is just plain nuts. So are those MSK ads...or maybe one should listen more carefully to the claims.